Cleveland Clinic-Led Research Finds Rivaroxaban Significantly Reduces Blood Clots and Blood Clot-Related Death in Cancer Patients
February 21, 2019
February 21, 2019
CLEVELAND, Ohio, Feb. 21 -- The Cleveland Clinic issued the following news release:
* * *
- Results of multicenter trial led by Alok Khorana, M.D., published in New England Journal of Medicine
* * *
Cleveland Clinic research has found that the blood thinner rivaroxaban significantly reduces venous thromboembolism (VTE) - a blood clot in the venous system - and VTE-related death for outpatient, high-risk cancer patients while they are taking the . . .
* * *
- Results of multicenter trial led by Alok Khorana, M.D., published in New England Journal of Medicine
* * *
Cleveland Clinic research has found that the blood thinner rivaroxaban significantly reduces venous thromboembolism (VTE) - a blood clot in the venous system - and VTE-related death for outpatient, high-risk cancer patients while they are taking the . . .